Icotinib-containing external use drug compound for skin and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
The technology of an external drug, Icotinib, is applied in the field of skin topical pharmaceutical composition
Inactive Publication Date: 2019-03-26
BETTA PHARM CO LTD
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There are currently no established psoriasis drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1-10
[0086] 1. Formulation (see Table 1)
[0087] Table 1
[0088]
[0089] 2. the preparation method of embodiment 1-10
[0090] (1) take the carbomer of recipe quantity, swell completely in propylene glycol;
[0091] (2) Weigh the Icotinib hydrochloride, Transcutol P and / or Labrasol of the prescribed amount respectively, and mix them uniformly;
[0092] (3) adding the mixture obtained in step (2) to the swollen carbomer solution obtained in step (1);
[0093] (4) Stir the mixture obtained in step (3) at room temperature until transparent.
Embodiment 11-14
[0095] 1. Formulation (see Table 2)
[0096] Table 2
[0097]
[0098] 2. The preparation method of embodiment 11-14
[0099] (1) Take respectively Icotinib hydrochloride, Transcutol P and Labrasol of prescription quantity, mix homogeneously;
[0100] (2) the mixture obtained in step (1) is added in the propylene glycol solution;
[0101] (3) Stir the mixture obtained in step (2) at room temperature until transparent.
Embodiment 15-20
[0103] 1. Formulation (see Table 3)
[0104] table 3
[0105]
[0106] 2. The preparation method of embodiment 15-20
[0107] (1) Carbomer and ethylparaben that take prescription quantity respectively, swell completely in propylene glycol;
[0108] (2) Take respectively Icotinib hydrochloride, Transcutol P and Labrasol of prescription quantity, mix homogeneously;
[0109] (3) adding the mixture obtained in step (2) to the swelled carbomer solution obtained in step (1);
[0110] (4) Stir the mixture obtained in step (3) at room temperature until it becomes transparent.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to an external use preparation for restraining tyrosine kinase and a preparation method thereof and especially relates to an external use drug compound for restraining tyrosine kinase and the preparation method thereof. Icotinib or a pharmacologically acceptable salt thereof is taken as an active ingredient of the external use preparation provided by the invention. The preparation is suitable for local application, has little skin irritation and has no adverse reaction, such as pruritus, burning sensation, pricking, dry skin, erythema and rash; no parahormone side effect,such as adermotrophia, chromatosis or lysis, occurs after long-term use of the preparation; no related dermatologic symptom occurs after drug withdrawal. The preparation method has the advantages ofsimple and easy operation and control, easiness in industrialization, and the like.
Description
[0001] This application is a divisional application of an application with an application date of October 11, 2014, an application number of 201480001225.7, and an invention title of "a pharmaceutical composition for external use containing icotinib and its application". technical field [0002] The invention relates to a skin external pharmaceutical composition containing icotinib or a pharmaceutically acceptable salt thereof and application thereof. Background technique [0003] Dermatosis is a disease related to the skin, and is one of common diseases and frequently-occurring diseases that seriously affect people's health, such as leprosy, scabies, fungal diseases, psoriasis, skin bacterial infections, etc. Dermatosis is the skin (including hair and nails) affected by internal and external factors, its shape, structure and function all change, resulting in pathological process, and correspondingly produce various clinical manifestations. The incidence of skin diseases is ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more